Opinion
Video
Kara Watts, MD, outlines SUO 2024 session on salvage focal ablation
Author(s):
Key Takeaways
- Focal ablation for radiorecurrent localized prostate cancer shows favorable functional outcomes compared to salvage radical prostatectomy.
- Current studies on salvage focal ablation are limited, but more data is anticipated as research progresses.
"I think the highlights are the functional outcomes after a salvage focal ablation are favorable, definitely, compared to salvage radical prostatectomy, but the studies are quite limited in terms of real salvage focal ablation," says Kara L. Watts, MD.
In this video, Kara L. Watts, MD, outlines her session on focal ablation from the Society of Urologic Oncology 25th Annual Meeting in Dallas, Texas. Watts is an associate professor of urology and the director of the Prostate Screening Program at Albert Einstein College of Medicine and Montefiore Medical Center in Bronx, New York.
Video Transcript:
The talk this year is on focal ablation for radiorecurrent localized prostate cancer. There's actually 3 talks in the session focusing on salvage radical prostatectomy, salvage radiation therapy, and salvage focal ablation. So really, the main points that I intend to cover this afternoon are what the options are in terms of salvage ablation focal modalities, and what some of the medium-term outcomes are in terms of oncologic cancer control compared to salvage radical prostatectomy and also salvage radiation therapy. I think the highlights are the functional outcomes after a salvage focal ablation are favorable, definitely, compared to salvage radical prostatectomy, but the studies are quite limited in terms of real salvage focal ablation. And we're going to see more emerging over time, similar to what we're seeing in the primary treatment setting as well.
This transcript was AI generated and edited by human editors for clarity.
